Prevalence and public health significance of Lyssavirus in bats in North region of Cameroon

Dah, I.; Namegni, R. S. P.; Mouiche, M. M. M.; Dickmu, S. J.; Nguena, R. G. N.; Conclois, I.; Florian, L.; God-Yang, L.; Feussom, J. M. K.; Wade, A.; Misse, D.; Awah-Ndukum, J.

doi:10.1101/2022.09.12.507528

bioRxiv · 10.1101/2022.09.12.507528

Prevalence and public health significance of Lyssavirus in bats in North region of Cameroon

Dah, I.·Namegni, R. S. P.·Mouiche, M. M. M.·Dickmu, S. J.·Nguena, R. G. N.·Conclois, I.·Florian, L.·God-Yang, L.·Feussom, J. M. K.·Wade, A.·Misse, D.·Awah-Ndukum, J.

View original source ↗Export metadata ↓

Abstract

BackgroundRabies is a zoonotic disease of all warm-blooded animals including humans. Though, there is little knowledge of the status of rabies in wild animals in Cameroon, the disease is endemic in the country with dogs being the main source of transmission. Bat habitats are widespread in Cameroon, but there is little information on the prevalence of rabies-like viruses in bats, nor the role of bats as a potential reservoir of rabies. MethodsA cross sectional study was carried out to determine the prevalence and risk factors of Lyssavirus in bats in the Northern region of Cameroon. A total of 212 bats belonging to three families (Pteropodidae, Vespertilionidae, Molossidae) and 5 species were randomly sampled in 7 localities in the North of Cameroon and were tested for Lyssavirus antigen using direct Immunofluorescence Test (IFA). Overall, 57 (26.89%) of the bats collected showed an IFA positive reaction. The prevalence was higher (P<0.05) in adult bats (33.33%, 95% CI: 25.15 - 42.66) compared to young individuals (20.19%). The main risk factors identified in the study for human exposure to bats were gender (Male), educational level (tertiary), religion (Christianity), ethnic group (Matal), the presence of bats in the area, the practice of bat hunting and consumption and the level of awareness on bat rabies-like viruses. ConclusionThe study found the first evidence of Lyssavirus in bats in Cameroon. This finding revealed that bat rabies-like viruses are real and constitutes a potential human health problem in communities with bat habitats in the North region of Cameroon. Enhancing the level of public awareness and health education on the potential of bats as reservoirs of Lyssavirus in Cameroon as well as the integration of the "One Health" approach for effective management of animal and human rabies should be emphasized. Author summaryRabies is a zoonotic disease caused by a virus of the genus Lyssavirus. It affects all warm-blooded animals including humans. Canine and Human rabies are well documented as endemic in Cameroon, but little is known about this disease in wildlife, in particular among bats, despite their multiple interactions with the inhabitants of Northern Cameroon. Indeed, bats were hunted, sold and eaten as bush meat by local populations. We investigated the presence of Lyssavirus in bat and assessed the risk factors of human exposure to bats in the Northern region of Cameroon. The study highlights that Lyssavirus is present in bats in this area. The population was aware of human and canine rabies, however, the presence of the disease in bats was less known. Based on these findings, investigating bat populations on a large scale, to characterise the Lyssavirus strains circulating in the region, as well as educate the local population on the risks of rabies transmission from bats to humans and other animals.

Explore related subjects

microbiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Dah, I., Namegni, R. S. P., Mouiche, M. M. M., Dickmu, S. J., Nguena, R. G. N., Conclois, I., Florian, L., God-Yang, L., Feussom, J. M. K., Wade, A., Misse, D., Awah-Ndukum, J.. 2022-09-12. Prevalence and public health significance of Lyssavirus in bats in North region of Cameroon. https://doi.org/10.1101/2022.09.12.507528

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗